Nancy Avila Biography and Net Worth

EVP of McKesson

Nancy Avila is Executive Vice President and Chief Information and Technology Officer for McKesson Corporation. As a member of the Executive Operating Team, Nancy leads McKesson’s technology initiatives, cybersecurity and guides the company’s overall technology strategy.

Nancy joined McKesson in 2020. Prior to McKesson, Nancy was Chief Information Officer at Johnson Controls, where she was responsible for information technology, cybersecurity and analytics. She also held roles with increasing responsibility during her 22-year career at Abbott, where she served as their VP and CIO of Global Business Services.

Nancy is devoted to making an impact in the community. She serves on Comerica's Board of Directors, Children’s Hospital of Wisconsin board, Dallas Regional Chamber (DRC) board, the World Economic Forum Governance on Digital Trust, and the Dallas Mavericks Advisory Council. Among her many achievements, The Greater Milwaukee Women’s Fund named Nancy as a 2019 Futurist Leader for her strong commitment to diversity and inclusion. In 2022, she was recognized for the third consecutive year by Hispanic IT Executive Council (HITEC) as one of the top 100 most influential Hispanic leaders in technology and D (Dallas) Magazine named her CIO/CTO of the year. Nancy is also the National Executive Sponsor for McKesson’s Women Empowered (WE) Employee Resource Group.

Nancy holds a bachelor’s degree in Mathematics and Computer Information Systems from Regis University and a master’s degree in Mathematics from the Colorado School of Mines.

What is Nancy Avila's net worth?: The estimated net worth of Nancy Avila is at least $6.02 million as of May 30th, 2023. Ms. Avila owns 10,390 shares of McKesson stock worth more than $6,023,499 as of December 21st. This net worth approximation does not reflect any other assets that Ms. Avila may own. Learn More about Nancy Avila's net worth.
How do I contact Nancy Avila?: The corporate mailing address for Ms. Avila and other McKesson executives is 6555 STATE HWY 161, IRVING TX, 75039. McKesson can also be reached via phone at (972) 446-4800 and via email at [email protected]. Learn More on Nancy Avila's contact information.
Has Nancy Avila been buying or selling shares of McKesson?: Nancy Avila has not been actively trading shares of McKesson during the last quarter. Most recently, Nancy Avila sold 1,330 shares of the business's stock in a transaction on Tuesday, May 30th. The shares were sold at an average price of $383.89, for a transaction totalling $510,573.70. Following the completion of the sale, the executive vice president now directly owns 10,390 shares of the company's stock, valued at $3,988,617.10. Learn More on Nancy Avila's trading history.
Who are McKesson's active insiders?: McKesson's insider roster includes Nancy Avila (EVP), James Beer (CFO), Kevin Emerson (CAO), Tracy Faber (EVP), Nancy Flores (EVP), John Hammergren (Chairman), Marie Knowles (Director), Erin Lampert (SVP), Maria Martinez (Director), Sundeep Reddy (SVP), Thomas Rodgers (EVP), Susan Salka (Director), Lori Schechter (EVP), LeAnn Smith (EVP), Brian Tyler (CEO), Brian Tyler (CEO), and Britt Vitalone (CFO). Learn More on McKesson's active insiders.
Are insiders buying or selling shares of McKesson?: During the last twelve months, insiders at the sold shares 17 times. They sold a total of 55,337 shares worth more than $30,142,665.33. The most recent insider tranaction occured on December, 9th when EVP Leann B Smith sold 579 shares worth more than $349,026.99. Insiders at McKesson own 0.1% of the company. Learn More about insider trades at McKesson.
Information on this page was last updated on 12/9/2024.

Nancy Avila Insider Trading History at McKesson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/30/2023	Sell	1,330	$383.89	$510,573.70	10,390
5/26/2023	Sell	491	$394.38	$193,640.58	11,720
2/3/2023	Sell	161	$370.02	$59,573.22	4,631

Nancy Avila Buying and Selling Activity at McKesson

McKesson Company Overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $579.74

$570.37

$583.93

50 Day Range

MA: $571.41

$499.18

$628.60

2 Week Range

Now: $579.74

$445.06

$637.51

Volume

2,057,107 shs

Average Volume

826,781 shs

Market Capitalization

$73.59 billion

P/E Ratio

30.02

Dividend Yield

0.50%

Beta

0.49

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.